カテゴリー： 世界, 部品/材料, LP Information

世界のキナクリン市場予測 2023年-2029年

【英語タイトル】Global Quinacrine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10545）・商品コード：LP23DC10545
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のキナクリン市場」は、過去の販売実績から2022年の世界のキナクリンの総販売量を検討し、2023年から2029年の予測されるキナクリンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のキナクリンの市場規模を掲載し、XXX百万米ドル規模の世界のキナクリン市場の詳細な分析を提供します。本インサイトレポートは、世界のキナクリン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のキナクリン市場における各社の独自のポジションをより深く理解するために、キナクリン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のキナクリン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。キナクリンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。キナクリンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。キナクリンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

キナクリンの世界主要メーカーとしては、MedChemExpress、 Sanofi-Aventis、 Pfizer、 Novartis、 Mylan、 Teva Pharmaceuticals、 Sandoz、 LGM Pharma、 Alfa Aesar、 Santa Cruz Biotechnology、 Sigma-Aldrichなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のキナクリン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではキナクリン市場をセグメンテーションし、種類別 (粉体、溶剤)、用途別 (医療研究、製薬)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：粉体、溶剤

・用途別区分：医療研究、製薬

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のキナクリン市場の10年間の市場状況・展望は？
・世界および地域別に見たキナクリン市場成長の要因は何か？
・キナクリンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・キナクリンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：キナクリンの年間販売量2018-2029、地域別現状・将来分析
・キナクリンの種類別セグメント：粉体、溶剤
・キナクリンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・キナクリンの用途別セグメント：医療研究、製薬
・キナクリンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のキナクリン市場
・企業別のグローバルキナクリン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のキナクリンの年間売上：2018-2023年の売上、市場シェア
・企業別のキナクリン販売価格
・主要企業のキナクリン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

キナクリンの地域別レビュー
・地域別のキナクリン市場規模2018-2023：年間販売量、売上
・主要国別のキナクリン市場規模2018-2023：年間販売量、売上
・南北アメリカのキナクリン販売の成長
・アジア太平洋のキナクリン販売の成長
・ヨーロッパのキナクリン販売の成長
・中東・アフリカのキナクリン販売の成長

南北アメリカ市場
・南北アメリカの国別のキナクリン販売量、売上（2018-2023）
・南北アメリカのキナクリンの種類別販売量
・南北アメリカのキナクリンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のキナクリン販売量、売上（2018-2023）
・アジア太平洋のキナクリンの種類別販売量
・アジア太平洋のキナクリンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のキナクリン販売量、売上（2018-2023）
・ヨーロッパのキナクリンの種類別販売量
・ヨーロッパのキナクリンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のキナクリン販売量、売上（2018-2023）
・中東・アフリカのキナクリンの種類別販売量
・中東・アフリカのキナクリンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・キナクリンの製造コスト構造分析
・キナクリンの製造プロセス分析
・キナクリンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・キナクリンの主要なグローバル販売業者
・キナクリンの主要なグローバル顧客

地域別のキナクリン市場予測レビュー
・地域別のキナクリン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・キナクリンの種類別市場規模予測
・キナクリンの用途別市場規模予測

主要企業分析
MedChemExpress、 Sanofi-Aventis、 Pfizer、 Novartis、 Mylan、 Teva Pharmaceuticals、 Sandoz、 LGM Pharma、 Alfa Aesar、 Santa Cruz Biotechnology、 Sigma-Aldrich
・企業情報
・キナクリン製品
・キナクリン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Quinacrine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Quinacrine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Quinacrine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Quinacrine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Quinacrine players cover MedChemExpress, Sanofi-Aventis, Pfizer, Novartis, Mylan, Teva Pharmaceuticals, Sandoz, LGM Pharma and Alfa Aesar, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Quinacrine Industry Forecast” looks at past sales and reviews total world Quinacrine sales in 2022, providing a comprehensive analysis by region and market sector of projected Quinacrine sales for 2023 through 2029. With Quinacrine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quinacrine industry.
This Insight Report provides a comprehensive analysis of the global Quinacrine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quinacrine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quinacrine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quinacrine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quinacrine.
This report presents a comprehensive overview, market shares, and growth opportunities of Quinacrine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Powder
Solvent
Segmentation by application
Medical Research
Pharma Engineering
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
MedChemExpress
Sanofi-Aventis
Pfizer
Novartis
Mylan
Teva Pharmaceuticals
Sandoz
LGM Pharma
Alfa Aesar
Santa Cruz Biotechnology
Sigma-Aldrich
Key Questions Addressed in this Report
What is the 10-year outlook for the global Quinacrine market?
What factors are driving Quinacrine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Quinacrine market opportunities vary by end market size?
How does Quinacrine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Quinacrine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Quinacrine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Quinacrine by Country/Region, 2018, 2022 & 2029
2.2 Quinacrine Segment by Type
2.2.1 Powder
2.2.2 Solvent
2.3 Quinacrine Sales by Type
2.3.1 Global Quinacrine Sales Market Share by Type (2018-2023)
2.3.2 Global Quinacrine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Quinacrine Sale Price by Type (2018-2023)
2.4 Quinacrine Segment by Application
2.4.1 Medical Research
2.4.2 Pharma Engineering
2.5 Quinacrine Sales by Application
2.5.1 Global Quinacrine Sale Market Share by Application (2018-2023)
2.5.2 Global Quinacrine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Quinacrine Sale Price by Application (2018-2023)
3 Global Quinacrine by Company
3.1 Global Quinacrine Breakdown Data by Company
3.1.1 Global Quinacrine Annual Sales by Company (2018-2023)
3.1.2 Global Quinacrine Sales Market Share by Company (2018-2023)
3.2 Global Quinacrine Annual Revenue by Company (2018-2023)
3.2.1 Global Quinacrine Revenue by Company (2018-2023)
3.2.2 Global Quinacrine Revenue Market Share by Company (2018-2023)
3.3 Global Quinacrine Sale Price by Company
3.4 Key Manufacturers Quinacrine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quinacrine Product Location Distribution
3.4.2 Players Quinacrine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Quinacrine by Geographic Region
4.1 World Historic Quinacrine Market Size by Geographic Region (2018-2023)
4.1.1 Global Quinacrine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Quinacrine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Quinacrine Market Size by Country/Region (2018-2023)
4.2.1 Global Quinacrine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Quinacrine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Quinacrine Sales Growth
4.4 APAC Quinacrine Sales Growth
4.5 Europe Quinacrine Sales Growth
4.6 Middle East & Africa Quinacrine Sales Growth
5 Americas
5.1 Americas Quinacrine Sales by Country
5.1.1 Americas Quinacrine Sales by Country (2018-2023)
5.1.2 Americas Quinacrine Revenue by Country (2018-2023)
5.2 Americas Quinacrine Sales by Type
5.3 Americas Quinacrine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quinacrine Sales by Region
6.1.1 APAC Quinacrine Sales by Region (2018-2023)
6.1.2 APAC Quinacrine Revenue by Region (2018-2023)
6.2 APAC Quinacrine Sales by Type
6.3 APAC Quinacrine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Quinacrine by Country
7.1.1 Europe Quinacrine Sales by Country (2018-2023)
7.1.2 Europe Quinacrine Revenue by Country (2018-2023)
7.2 Europe Quinacrine Sales by Type
7.3 Europe Quinacrine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Quinacrine by Country
8.1.1 Middle East & Africa Quinacrine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Quinacrine Revenue by Country (2018-2023)
8.2 Middle East & Africa Quinacrine Sales by Type
8.3 Middle East & Africa Quinacrine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quinacrine
10.3 Manufacturing Process Analysis of Quinacrine
10.4 Industry Chain Structure of Quinacrine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quinacrine Distributors
11.3 Quinacrine Customer
12 World Forecast Review for Quinacrine by Geographic Region
12.1 Global Quinacrine Market Size Forecast by Region
12.1.1 Global Quinacrine Forecast by Region (2024-2029)
12.1.2 Global Quinacrine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Quinacrine Forecast by Type
12.7 Global Quinacrine Forecast by Application
13 Key Players Analysis
13.1 MedChemExpress
13.1.1 MedChemExpress Company Information
13.1.2 MedChemExpress Quinacrine Product Portfolios and Specifications
13.1.3 MedChemExpress Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MedChemExpress Main Business Overview
13.1.5 MedChemExpress Latest Developments
13.2 Sanofi-Aventis
13.2.1 Sanofi-Aventis Company Information
13.2.2 Sanofi-Aventis Quinacrine Product Portfolios and Specifications
13.2.3 Sanofi-Aventis Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi-Aventis Main Business Overview
13.2.5 Sanofi-Aventis Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Quinacrine Product Portfolios and Specifications
13.3.3 Pfizer Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Quinacrine Product Portfolios and Specifications
13.4.3 Novartis Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Quinacrine Product Portfolios and Specifications
13.5.3 Mylan Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Teva Pharmaceuticals
13.6.1 Teva Pharmaceuticals Company Information
13.6.2 Teva Pharmaceuticals Quinacrine Product Portfolios and Specifications
13.6.3 Teva Pharmaceuticals Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceuticals Main Business Overview
13.6.5 Teva Pharmaceuticals Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Quinacrine Product Portfolios and Specifications
13.7.3 Sandoz Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 LGM Pharma
13.8.1 LGM Pharma Company Information
13.8.2 LGM Pharma Quinacrine Product Portfolios and Specifications
13.8.3 LGM Pharma Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 LGM Pharma Main Business Overview
13.8.5 LGM Pharma Latest Developments
13.9 Alfa Aesar
13.9.1 Alfa Aesar Company Information
13.9.2 Alfa Aesar Quinacrine Product Portfolios and Specifications
13.9.3 Alfa Aesar Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Alfa Aesar Main Business Overview
13.9.5 Alfa Aesar Latest Developments
13.10 Santa Cruz Biotechnology
13.10.1 Santa Cruz Biotechnology Company Information
13.10.2 Santa Cruz Biotechnology Quinacrine Product Portfolios and Specifications
13.10.3 Santa Cruz Biotechnology Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Santa Cruz Biotechnology Main Business Overview
13.10.5 Santa Cruz Biotechnology Latest Developments
13.11 Sigma-Aldrich
13.11.1 Sigma-Aldrich Company Information
13.11.2 Sigma-Aldrich Quinacrine Product Portfolios and Specifications
13.11.3 Sigma-Aldrich Quinacrine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sigma-Aldrich Main Business Overview
13.11.5 Sigma-Aldrich Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Quinacrine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Quinacrine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Solvent
Table 5. Global Quinacrine Sales by Type (2018-2023) & (Tons)
Table 6. Global Quinacrine Sales Market Share by Type (2018-2023)
Table 7. Global Quinacrine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Quinacrine Revenue Market Share by Type (2018-2023)
Table 9. Global Quinacrine Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Quinacrine Sales by Application (2018-2023) & (Tons)
Table 11. Global Quinacrine Sales Market Share by Application (2018-2023)
Table 12. Global Quinacrine Revenue by Application (2018-2023)
Table 13. Global Quinacrine Revenue Market Share by Application (2018-2023)
Table 14. Global Quinacrine Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Quinacrine Sales by Company (2018-2023) & (Tons)
Table 16. Global Quinacrine Sales Market Share by Company (2018-2023)
Table 17. Global Quinacrine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Quinacrine Revenue Market Share by Company (2018-2023)
Table 19. Global Quinacrine Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Quinacrine Producing Area Distribution and Sales Area
Table 21. Players Quinacrine Products Offered
Table 22. Quinacrine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Quinacrine Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Quinacrine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Quinacrine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Quinacrine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Quinacrine Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Quinacrine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Quinacrine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Quinacrine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Quinacrine Sales by Country (2018-2023) & (Tons)
Table 34. Americas Quinacrine Sales Market Share by Country (2018-2023)
Table 35. Americas Quinacrine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Quinacrine Revenue Market Share by Country (2018-2023)
Table 37. Americas Quinacrine Sales by Type (2018-2023) & (Tons)
Table 38. Americas Quinacrine Sales by Application (2018-2023) & (Tons)
Table 39. APAC Quinacrine Sales by Region (2018-2023) & (Tons)
Table 40. APAC Quinacrine Sales Market Share by Region (2018-2023)
Table 41. APAC Quinacrine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Quinacrine Revenue Market Share by Region (2018-2023)
Table 43. APAC Quinacrine Sales by Type (2018-2023) & (Tons)
Table 44. APAC Quinacrine Sales by Application (2018-2023) & (Tons)
Table 45. Europe Quinacrine Sales by Country (2018-2023) & (Tons)
Table 46. Europe Quinacrine Sales Market Share by Country (2018-2023)
Table 47. Europe Quinacrine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Quinacrine Revenue Market Share by Country (2018-2023)
Table 49. Europe Quinacrine Sales by Type (2018-2023) & (Tons)
Table 50. Europe Quinacrine Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Quinacrine Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Quinacrine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Quinacrine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Quinacrine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Quinacrine Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Quinacrine Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Quinacrine
Table 58. Key Market Challenges & Risks of Quinacrine
Table 59. Key Industry Trends of Quinacrine
Table 60. Quinacrine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Quinacrine Distributors List
Table 63. Quinacrine Customer List
Table 64. Global Quinacrine Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Quinacrine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Quinacrine Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Quinacrine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Quinacrine Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Quinacrine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Quinacrine Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Quinacrine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Quinacrine Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Quinacrine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Quinacrine Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Quinacrine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Quinacrine Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Quinacrine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MedChemExpress Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 79. MedChemExpress Quinacrine Product Portfolios and Specifications
Table 80. MedChemExpress Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. MedChemExpress Main Business
Table 82. MedChemExpress Latest Developments
Table 83. Sanofi-Aventis Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi-Aventis Quinacrine Product Portfolios and Specifications
Table 85. Sanofi-Aventis Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Sanofi-Aventis Main Business
Table 87. Sanofi-Aventis Latest Developments
Table 88. Pfizer Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Quinacrine Product Portfolios and Specifications
Table 90. Pfizer Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Novartis Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Quinacrine Product Portfolios and Specifications
Table 95. Novartis Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Mylan Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Quinacrine Product Portfolios and Specifications
Table 100. Mylan Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Teva Pharmaceuticals Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Pharmaceuticals Quinacrine Product Portfolios and Specifications
Table 105. Teva Pharmaceuticals Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Teva Pharmaceuticals Main Business
Table 107. Teva Pharmaceuticals Latest Developments
Table 108. Sandoz Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sandoz Quinacrine Product Portfolios and Specifications
Table 110. Sandoz Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Sandoz Main Business
Table 112. Sandoz Latest Developments
Table 113. LGM Pharma Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 114. LGM Pharma Quinacrine Product Portfolios and Specifications
Table 115. LGM Pharma Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. LGM Pharma Main Business
Table 117. LGM Pharma Latest Developments
Table 118. Alfa Aesar Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 119. Alfa Aesar Quinacrine Product Portfolios and Specifications
Table 120. Alfa Aesar Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Alfa Aesar Main Business
Table 122. Alfa Aesar Latest Developments
Table 123. Santa Cruz Biotechnology Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 124. Santa Cruz Biotechnology Quinacrine Product Portfolios and Specifications
Table 125. Santa Cruz Biotechnology Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Santa Cruz Biotechnology Main Business
Table 127. Santa Cruz Biotechnology Latest Developments
Table 128. Sigma-Aldrich Basic Information, Quinacrine Manufacturing Base, Sales Area and Its Competitors
Table 129. Sigma-Aldrich Quinacrine Product Portfolios and Specifications
Table 130. Sigma-Aldrich Quinacrine Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Sigma-Aldrich Main Business
Table 132. Sigma-Aldrich Latest Developments
List of Figures
Figure 1. Picture of Quinacrine
Figure 2. Quinacrine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quinacrine Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Quinacrine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Quinacrine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Solvent
Figure 11. Global Quinacrine Sales Market Share by Type in 2022
Figure 12. Global Quinacrine Revenue Market Share by Type (2018-2023)
Figure 13. Quinacrine Consumed in Medical Research
Figure 14. Global Quinacrine Market: Medical Research (2018-2023) & (Tons)
Figure 15. Quinacrine Consumed in Pharma Engineering
Figure 16. Global Quinacrine Market: Pharma Engineering (2018-2023) & (Tons)
Figure 17. Global Quinacrine Sales Market Share by Application (2022)
Figure 18. Global Quinacrine Revenue Market Share by Application in 2022
Figure 19. Quinacrine Sales Market by Company in 2022 (Tons)
Figure 20. Global Quinacrine Sales Market Share by Company in 2022
Figure 21. Quinacrine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Quinacrine Revenue Market Share by Company in 2022
Figure 23. Global Quinacrine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Quinacrine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Quinacrine Sales 2018-2023 (Tons)
Figure 26. Americas Quinacrine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Quinacrine Sales 2018-2023 (Tons)
Figure 28. APAC Quinacrine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Quinacrine Sales 2018-2023 (Tons)
Figure 30. Europe Quinacrine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Quinacrine Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Quinacrine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Quinacrine Sales Market Share by Country in 2022
Figure 34. Americas Quinacrine Revenue Market Share by Country in 2022
Figure 35. Americas Quinacrine Sales Market Share by Type (2018-2023)
Figure 36. Americas Quinacrine Sales Market Share by Application (2018-2023)
Figure 37. United States Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Quinacrine Sales Market Share by Region in 2022
Figure 42. APAC Quinacrine Revenue Market Share by Regions in 2022
Figure 43. APAC Quinacrine Sales Market Share by Type (2018-2023)
Figure 44. APAC Quinacrine Sales Market Share by Application (2018-2023)
Figure 45. China Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Quinacrine Sales Market Share by Country in 2022
Figure 53. Europe Quinacrine Revenue Market Share by Country in 2022
Figure 54. Europe Quinacrine Sales Market Share by Type (2018-2023)
Figure 55. Europe Quinacrine Sales Market Share by Application (2018-2023)
Figure 56. Germany Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Quinacrine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Quinacrine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Quinacrine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Quinacrine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Quinacrine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Quinacrine in 2022
Figure 71. Manufacturing Process Analysis of Quinacrine
Figure 72. Industry Chain Structure of Quinacrine
Figure 73. Channels of Distribution
Figure 74. Global Quinacrine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Quinacrine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Quinacrine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Quinacrine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Quinacrine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Quinacrine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のキナクリン市場予測 2023年-2029年] (コード：LP23DC10545)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のキナクリン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のキナクリン二塩酸塩市場予測 2023年-2029年
  • 世界のスライドウェイ潤滑剤市場予測 2023年-2029年
  • 世界の封蝋市場予測 2023年-2029年
  • 世界の紡績油市場予測 2023年-2029年
  • 世界のボディペイント用安全塗料市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆